Concepedia

Jeremy Fry

JF

Statistics

Publications

10

Citations

2.2K

H-Index

10

Active since

1999

Affiliations

ProImmune (United Kingdom)(Current)

Tumor Hospital of Xinjiang Medical University

Centre for Human Genetics

University of Oxford

MRC Weatherall Institute of Molecular Medicine

Jeremy Fry is an author at ProImmune (United Kingdom) specializing in immunotherapy, immunology, and medicine.

ORCID

Top concepts

Publications per year

1999–2022

10

Publications

10

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Yanchun Peng, Alexander J. Mentzer, Guihai Liu et al. · Nature Immunology · 2020 · 1.4K citations · Full text

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

Karsten Geletneky, Jacek Hajda, Assia L. Angelova et al. · Molecular Therapy · 2017 · 249 citations · Full text

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Yanchun Peng, Suet Ling Felce, Danning Dong et al. · Nature Immunology · 2021 · 180 citations · Full text

Fc-engineered antibodies with immune effector functions completely abolished

Ian Wilkinson, Stephen F. Anderson, Jeremy Fry et al. · PLoS ONE · 2021 · 103 citations · Full text

, , +24

In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue

Zhi Li, Zewen Kelvin Tuong, Isaac Dean et al. · The Journal of Experimental Medicine · 2022 · 102 citations · Full text

, , +17

1–5 of 10